Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Stroke. 2019 Sep 12;50(10):2761–2767. doi: 10.1161/STROKEAHA.119.025738

Table 1:

Study cohort characterization. Treatment included intravenous tPA or endovascular thrombectomy. There was no difference in patients with and without fMRI data (p>0.2). (sd: standard deviation; IQR: interquartile range)

SALVO Patients with fMRI data
n 41 33
NRC (mean (sd)) 0.59 (0.81) 0.52 (0.80)
DWIv (cc; mean (sd)) 9.13 (12.52) 9.54 (13.49)
Age (years; mean (sd)) 69.79 (9.70) 70.03 (10.21)
Sex (male; %) 25 (61.0) 20 (60.6)
mRSpre (mean (sd)) 0.29 (0.75) 0.36 (0.82)
mRS (median (IQR); 1 N/A) 1 (2) 1 (2.25)
NIHSSadm (mean (sd); 1 N/A) 8.03 (5.54) 8.28 (5.85)
NIHSSearly (mean (sd)) 4.85 (4.95) 5.12 (5.34)
NIHSSlate (mean (sd); 13 N/A) 1.32 (2.25) 1.29 (2.47)
Stroke location (left; %) 16 (39.0) 11 (33.3)
Treatment (%) 18 (43.9) 13 (39.4)
LHO+ (mean (sd)) 17.66 (1.01)
LHO (mean (sd)) 20.91 (1.61)
LHOabs (mean (sd)) 15.21 (0.92)
LAAL+ (mean (sd)) 17.57 (1.14)
LAAL (mean (sd)) 20.39 (1.62)
LAALabs (mean (sd)) 14.98 (0.98)
LDes+ (mean (sd)) 20.12 (1.20)
LDes (mean (sd)) 24.13 (1.95)
LDesabs (mean (sd)) 17.62 (1.12)